Biohaven Reports Financial Results for Q3 2025 and Strategic Developments in Drug Pipeline Biohaven Ltd. shared its financial results for Q3 2025, highlighting advancements in clinical programs and a focus on optimizing resources for innovative therapies.

Biohaven Reports Financial Results for Q3 2025 and Strategic Developments in Drug Pipeline #USA #Biohaven #New_Haven #BHVN #Opakalim